Back to search
Prophylaxis Invasive Pneumococcal Diseases and Pneumonia
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Prophylaxis Invasive Pneumococcal Diseases and Pneumonia trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Prophylaxis Invasive Pneumococcal Diseases and Pneumonia trials you may qualify forAs the licensed Pneumovax 23™ vaccine is not always satisfactory in elderly subjects, the safety and the immune response of the new investigational pneumococcal…
As the licensed pneumococcal vaccine is not always satisfactory in elderly, new investigational pneumococcal vaccines are evaluated in the healthy elderly popul…
This study is to describe the safety and immunogenicity of 13vPnC in Indian adults 50 to 65 years of age and in Indian children 6 to 17 years of age.
The purpose of this study is to assess the efficacy of 13-valent pneumococcal conjugate vaccine in the prevention of the first episode of vaccine-type pneumococ…
Streptococcus pneumoniae are bacteria which normally live in the upper respiratory tract of humans. However, these bacteria can also cause severe infectious dis…